MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to Mi…
| Métrica | HYFT | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 55.3% | 57.4% | -2.1% |
| Operating Margin | — | -34.4% | — |
| Net Margin | -123.3% | -32.5% | -90.8% |
| FCF Margin | -29.4% | -12.6% | -16.8% |
| ROE | -128.0% | -39.2% | -88.8% |
| ROA | -68.0% | -30.9% | -37.1% |
| Current Ratio | 2.08 | 2.73 | -0.65 |
| Debt / Equity | — | 0.28 | — |
| Tendencia (Piotroski) | FY25 | FY24 |
|---|---|---|
| ✗Rentabilidad sobre activos positiva | -68.0% | — |
| ✗Flujo de caja operativo positivo | −CA$6M | −CA$3M |
| ✗Rentabilidad sobre activos al alza | -68.0% | -43.5% |
| ✓Caja operativa/activos supera al ROA | -14.4% | ROA -68.0% |
| –Menos deuda a largo plazo | — | — |
| ✓Mejor liquidez (ratio corriente) | 2.08 | 1.41 |
| ✗Sin aumentar el nº de acciones | 33M | 26M |
| ✓Margen bruto al alza | 55.3% | 49.2% |
| ✓Rotación de activos al alza | 0.55 | 0.41 |
| Calidad del negocio | FY25 |
|---|---|
| ✗Margen FCF > 10 % | -29.4% |
| ✓Ventas > 5 %/año (3 años) | 8.2% |
| ✓Reinversión (I+D + capex) > 3 % de ventas | 23.4% |
MindWalk Holdings Corp. cotiza a 1.31 USD y tiene una capitalización bursátil de $62M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud